Your browser doesn't support javascript.
loading
Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas.
Janeczko-Czarnecka, Malgorzata; Krawczuk-Rybak, Maryna; Karpinska-Derda, Irena; Niedzwiecki, Maciej; Musiol, Katarzyna; Cwiklinska, Magdalena; Drabko, Katarzyna; Mycko, Katarzyna; Ociepa, Tomasz; Pawelec, Katarzyna; Januszkiewicz-Lewandowska, Danuta; Ussowicz, Marek; Rybka, Blanka; Ryczan-Krawczyk, Renata; Koltan, Andrzej; Karolczyk, Grazyna; Zaucha-Prazmo, Agnieszka; Badowska, Wanda; Kalwak, Krzysztof.
Afiliação
  • Janeczko-Czarnecka M; Department and Clinic of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, Poland.
  • Krawczuk-Rybak M; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, Poland.
  • Karpinska-Derda I; Department of Pediatrics, Hematology and Oncology, Dr Edward Hanke Chorzów Center of Pediatrics and Oncology, Poland.
  • Niedzwiecki M; Department and Clinic of Pediatrics, Hematology and Oncology, Medical University of Gdansk, Poland.
  • Musiol K; Silesian Children's Health Center, Department of Oncology, Hematology and Pediatric Chemotherapy, Medical University of Silesia in Katowice, Poland.
  • Cwiklinska M; Department of Oncology and Hematology, Polish-American Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland.
  • Drabko K; Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Poland.
  • Mycko K; Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.
  • Ociepa T; Department of Pediatrics, Pediatric Hematology and Oncology, Pomeranian Medical University in Szczecin, Poland.
  • Pawelec K; Department and Clinic of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Poland.
  • Januszkiewicz-Lewandowska D; Department of Oncology, Hematology and Pediatric Transplantatology, Poznan University of Medical Sciences, Poland.
  • Ussowicz M; Department and Clinic of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, Poland.
  • Rybka B; Department and Clinic of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, Poland.
  • Ryczan-Krawczyk R; Department and Clinic of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, Poland.
  • Koltan A; Department of Pediatrics, Hematology and Oncology, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Poland.
  • Karolczyk G; Department of Hematooncology, Wladyslaw Buszkowski Provincial Specialist Children's Hospital in Kielce, Poland.
  • Zaucha-Prazmo A; Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Poland.
  • Badowska W; Department and Clinic of Pediatric Hematology and Oncology, Prof. Stanislaw Popowski Provincial Specialist Childrens' Hospital in Olsztyn, Poland.
  • Kalwak K; Department and Clinic of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, Poland.
Adv Clin Exp Med ; 27(1): 91-98, 2018 Jan.
Article em En | MEDLINE | ID: mdl-29521048
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Adv Clin Exp Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Polônia País de publicação: Polônia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Adv Clin Exp Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Polônia País de publicação: Polônia